4//SEC Filing
CARE CAPITAL II LLC 4
Accession 0001104659-13-038977
CIK 0000786947other
Filed
May 7, 8:00 PM ET
Accepted
May 8, 5:58 PM ET
Size
9.2 KB
Accession
0001104659-13-038977
Insider Transaction Report
Form 4
CARE CAPITAL INVESTMENTS II LP
10% Owner
Transactions
- Sale
Common Stock
2013-05-08$2.15/sh−62,000$133,300→ 7,511,815 total(indirect: See Footnote)
Transactions
- Sale
Common Stock
2013-05-08$2.15/sh−62,000$133,300→ 7,511,815 total(indirect: See Footnote)
CARE CAPITAL II LLC
10% Owner
Transactions
- Sale
Common Stock
2013-05-08$2.15/sh−62,000$133,300→ 7,511,815 total(indirect: See Footnote)
Footnotes (3)
- [F1]The shares were sold as follows: 58,019 by Care Capital Investments II, LP and 3,981 by Care Capital Offshore Investments II, L.P.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.21 to $2.11, inclusive. The reporting person undertakes to provide to Acura Pharmaceuticals, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
- [F3]Consists of 7,029,571 shares held by Care Capital Investments II, LP and 482,244 shares held by Care Capital Offshore Investments II, L.P. Care Capital II, LLC is the general partner of Care Capital Investments II, LP and Care Capital Offshore Investments II, LP and as a result, Care Capital II, LLC has the ultimate power to vote or direct the vote and to dispose or direct the disposition of such shares. Care Capital II, LLC is managed by three or more members and accordingly none of the managing members is deemed to have voting or dispositive control over the securities.
Documents
Issuer
ACURA PHARMACEUTICALS, INC
CIK 0000786947
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001212648
Filing Metadata
- Form type
- 4
- Filed
- May 7, 8:00 PM ET
- Accepted
- May 8, 5:58 PM ET
- Size
- 9.2 KB